Hemophilus influenzae type b meningitis in infant rabbits. Pathogenesis and therapy

Related Experiment Videos

Insights

This study developed a rabbit model for Haemophilus influenzae type b meningitis, revealing host factors influencing infection. Aztreonam treatment significantly reduced mortality in established meningitis.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Animal Models

Background:

  • Haemophilus influenzae type b (Hib) is a major cause of bacterial meningitis.
  • Understanding Hib pathogenesis and effective treatment is crucial.

Purpose of the Study:

  • To develop an infant rabbit model for studying Hib meningitis.
  • To investigate factors influencing Hib colonization and infection.
  • To evaluate the efficacy of aztreonam in treating established Hib meningitis.

Main Methods:

  • Infant rabbits were infected intranasally with Hib.
  • Nasopharyngeal mucosa was pretreated with trypsin or saline.
  • Bacteremia and meningitis development were monitored.
  • Aztreonam pharmacokinetics in cerebrospinal fluid (CSF) were assessed.
  • Mortality rates were compared between treated and untreated groups.

Main Results:

  • The rabbit model mimicked human Hib meningitis, with high mortality.
  • Nasopharyngeal pretreatment increased bacteremia rates.
  • Aztreonam achieved 6-7% serum concentration in infected CSF, versus 2-3% in normal CSF.
  • Aztreonam reduced mortality from 88% to 9% in established meningitis.

Conclusions:

  • Host factors on respiratory epithelial cells influence Hib colonization.
  • The rabbit model is valuable for studying Hib meningitis.
  • Aztreonam is highly effective in treating established Hib meningitis in this model.

Related Concept Videos